Physician profile
Mava Briana Robinson-Walton
NPI 1447222088
$257,376.48
in general payments reported to CMS, 2019-2025
28 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $2,902 · 2021: $20K · 2022: $5,871 · 2023: $50K · 2024: $62K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $130K · Travel and Lodging: $19K · Education: $12K · Food and Beverage: $7,406 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $130,072.08 |
| Travel and Lodging | $18,804.59 |
| Education | $12,099.95 |
| Food and Beverage | $7,405.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $237,678.85 | 2019-2025 | Altis, Saffron |
| Intuitive Surgical, INC. | $16,066.66 | 2022-2024 | Da Vinci Surgical System |
| Baxter Healthcare | $892.45 | 2021-2025 | Perclot, Tisseel, Floseal |
| Abbvie INC. | $833.72 | 2020-2025 | Botox, Lo Loestrin Fe, Orilissa |
| Axonics, INC. | $467.74 | 2022-2024 | Axonics, Bulkamid |
| Allergan, INC. | $242.56 | 2019-2022 | |
| Astellas Pharma US INC | $221.04 | 2019-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $168.11 | 2019-2022 | |
| Myovant Sciences INC. | $125.00 | 2022 | |
| Hologic Sales and Service, LLC | $85.14 | 2019-2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Conmed Corporation | $72.26 | 2021-2024 | Airseal |
| Coopersurgical, INC. | $57.96 | 2022-2023 | Wallach Cryosurgical Equipment |
| Pfizer INC. | $57.42 | 2020-2023 | |
| Davol INC. | $56.69 | 2021 | |
| Medtronic, INC. | $56.07 | 2025 | Intellis Adaptivestim |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $49.58 | 2025 | Myfembree |
| Applied Medical Resources Corporation | $40.79 | 2025 | |
| United Therapeutics Corporation | $31.80 | 2025 | Tyvaso |
| Innovation Technologies INC | $22.89 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $22.46 | 2025 | Tezspire |
| Abbott Laboratories | $20.73 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.03 | 2019 | |
| Verona Pharma, INC. | $17.91 | 2025 | Ohtuvayre |
| Seqirus USA INC | $16.88 | 2025 | Fluad, Flucelvax |
| Aspira Women'S Health INC | $14.55 | 2022 | |
| Arteriocyte Medical Systems, INC. | $13.34 | 2021 | |
| Meditrina | $13.08 | 2024 | |
| Duchesnay USA Incorporated | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mava Robinson-Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.